ArticleActa neurologica Belgica2026
Atypical clinical manifestation of MT-TL1 mutation in 6 months old patient.
Article in Acta neurologica Belgica, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe mitochondrial tRNALeu (MT-TL1) m.3243A > G mutation is one of the most frequent pathogenic variants in mtDNA which is associated with various clinical syndromes including Mitochondrial Encephalomyopathy, Lactic Acidosis and Stroke-like episodes (MELAS). The onset of symptoms associated with the MT-TL1 mutation typically occurs in adolescence or early adulthood. Due to the diversity of its clinical presentation, there is a need to report all cases that do not fully meet the criteria of well-established clinical syndromes. CASE PRESENTATION: This paper reports a case of a 3-year-old male patient with a complex perinatal history, whose symptoms emerged at 6 months of age and included epileptic seizures, developmental delay, bilateral convergent strabismus, hypertonia, hyperreflexia, and radiological brain abnormalities. The family history is positive for epilepsy and hearing impairment in females on the maternal side. Genetic testing revealed a pathological variant in the MT-TL1 gene m.3243A > G with a high heteroplasmy level of 76.5% in the blood sample.
conclusionThe case presents an atypical manifestation of the m.3243A > G mutation, highlighting the importance of genetic screening for mitochondrial disorders in patients with a maternal family history.
Indexed as
Identifiers
41171526What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.